abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

The content is also available in the following languages: español

Company Response

Pfizer response on Honduran decree declaring information agreed with Covid-19 vaccine companies confidential

...Pfizer is very proud to work with the government of Honduras in this effort to combat the pandemic. We have concluded agreements to supply over 140 countries, and we are currently in advanced negotiations with many more, where we have followed a consistent negotiation process for the supply of Pfizer and BioNTech's COVID-19 vaccine, both in Central America and the Caribbean and globally...

...[W]e would like to inform that at no time has Pfizer requested the issuance of a law that decrees the confidentiality of the manufacturing and distribution agreement of Pfizer and BioNTech's vaccine against COVID-19. While we have requested that certain details of our contracts be kept confidential, this has been to avoid prejudice to ongoing negotiations around the world, protect our right to fair competition and prevent third parties from gaining access to commercial information that could be used in dishonest ways. It is also important to emphasize that such confidentiality does not prevent or limit, in any way, the exercise of the supervisory powers of the competent authorities...

We remain fully focused on getting high-quality, safe and effective vaccines to patients all over the world as quickly as possible and to helping end this deadly pandemic...

Story Timeline